Oregon Medical Grass

Acomplia (rimonabant) is an anti-obesity drug. It was approved for marketing in the European Union in June 2006. Rimonabant is not yet approved for use in the United States, where it is known as Zimulti. Acomplia (rimonabant) is the first in a new class of therapeutic agents called Cannabinoid-1 Receptor Blockers (CB1). Acomplia is used in the treatment of obesity and related conditions. Acomplia acts by selectively blocking CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism, including adipose tissue, the liver, gastrointestinal tract and muscle. Acomplia switches off the same brain circuits that make people hungry when they smoke cannabis. CB1 receptor blockade with Acomplia acts to decrease the overactivity of the endocannabinoid system (EC system)2,3. The EC system is a recently characterised physiological system that includes receptors such as the CB1 receptor and it has been shown to play an important role in regulating body weight and in controlling energy balance, as well as glucose and lipid (or fat) metabolism.

Known in the the US by its generic name Rimonabant, Acomplia is hailed as a miracle weight loss pill. It is considered an anoretic anti-obesity drug and the first CB1 receptor blocker to be approved for use. It has been made available to Europeans since 2006, but is still awaiting approval by the FDA. In Europe, Acomplia drug loss weight is indicated for use in conjunction with exercise and diet for patients who have a body mass index that is greater than 30 kg/m² (or greater than 27 kg/m² for those with risk factors, i.e. type 2 diabetes and dyslipidaemia).

Order cheap Acomplia medication without prescription

Usually, weight loss pills carry a potential for abuse, and in this case, abuse could carry potentially serious side effects. Some common side effects includes constipation, bloating, insomnia, diarrhea, nausea, indigestion, vomiting, heart palpitations and stroke.

Consumers in most cases are prompted to believe they can’t lose weight themselves through self-discipline, diet and exercise. They become dependent on the diet pills and feel ineffective without them. However, those that use them wisely find themselves consuming fewer calories and lose twice the weight than if you attempt to diet without weight loss pills.

Why should one go for weight loss programme?

The obvious answer would be, just to look better. But apart from looking good, one should be free from fatty body for the sake of healthy living and to avoid diseases associated with being obese. Loosing unwanted fats from the body is not at all a bad deal when it gives you life style worry free.

In a series of trials involving more than 6,000 patients in the US and Europe, a quarter lost more than 10% of their initial body weight after a year. About half lost more than 5%.

Side effects in some patients included nausea, dizziness and anxiety.

Other benefits

- Significant improvements in measures of glucose control, cholesterol and triglyceride blood fats were also seen.

- It is currently licensed for the treatment of obese patients, or overweight patients with associated risk factors such as type 2 diabetes or poor cholesterol and triglyceride readings.

- Clinical trials have shown that heavy smokers, after being on a regular supplement of Rimonabant, have stopped smoking altogether.

There is no reason why you can’t have slim and sexy body!

If you went to college in the 60?s and 70?s you may remember the ?munchies? or voracious appetite which sometimes accompanied marijuana smoking. Little did the pot heads of that day realize that medications in the future which block the munchies would help them shed the pounds that they would gain over the next 30 or so years.

This new medication, ramonabant (affectionately known at metabolism.com as Ramona), brand name Acomplia, is presently available in Europe an&
#100; may soon be available in the United States. The company which produces this medication, Sanofi-Aventis, has been in lengthy negotiations with the FDA regarding gaining the critical approval required to bring Acomplia to market in the U.S. There has been much speculation about the reasons for the lengthy delay in gaining approval from the FDA. One possible reason is that although extensive clinical trials suggest that the new drug is safe and effective for weight loss, many experts are concerned about potential side-effects of ramonabant.

Read more about Acomplia and other weight loss medications at European pharmacy.